Illumina Body Map 2 (GSE30611)
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
SOX17 | hg38_v1_chr8_+_54457927_54457943 | -0.18 | 3.3e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chrY_+_2841864 Show fit | 7.43 |
ENST00000430575.1
|
ribosomal protein S4 Y-linked 1 |
|
chr12_-_110920568 Show fit | 5.58 |
ENST00000548438.1
ENST00000228841.15 |
myosin light chain 2 |
|
chr11_-_118225002 Show fit | 2.83 |
ENST00000356289.10
ENST00000526620.5 |
junction adhesion molecule like |
|
chr7_+_142352802 Show fit | 2.81 |
ENST00000634605.1
|
T cell receptor beta variable 7-2 |
|
chr12_-_110920710 Show fit | 2.62 |
ENST00000546404.1
|
myosin light chain 2 |
|
chr11_-_116837586 Show fit | 2.58 |
ENST00000375320.5
ENST00000359492.6 ENST00000375329.6 ENST00000375323.5 ENST00000236850.5 |
apolipoprotein A1 |
|
chr13_-_46211841 Show fit | 2.23 |
ENST00000442275.1
|
lymphocyte cytosolic protein 1 |
|
chr8_-_17895487 Show fit | 2.19 |
ENST00000427924.5
ENST00000381841.4 |
fibrinogen like 1 |
|
chr1_+_40374648 Show fit | 2.02 |
ENST00000372708.5
|
small ArfGAP2 |
|
chr16_+_2817230 Show fit | 2.01 |
ENST00000005995.8
ENST00000574813.5 |
serine protease 21 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 8.3 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.6 | 8.2 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
0.0 | 7.9 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.1 | 6.1 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.0 | 4.5 | GO:0002377 | immunoglobulin production(GO:0002377) |
0.0 | 4.0 | GO:0030317 | sperm motility(GO:0030317) |
1.1 | 3.2 | GO:0002728 | negative regulation of natural killer cell cytokine production(GO:0002728) |
0.1 | 2.9 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
0.3 | 2.8 | GO:0035696 | monocyte extravasation(GO:0035696) |
0.9 | 2.6 | GO:0045957 | regulation of complement activation, alternative pathway(GO:0030451) negative regulation of complement activation, alternative pathway(GO:0045957) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 8.3 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
0.5 | 8.2 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.1 | 7.3 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.0 | 4.3 | GO:0016605 | PML body(GO:0016605) |
0.0 | 4.0 | GO:0101003 | ficolin-1-rich granule membrane(GO:0101003) |
0.3 | 3.9 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.3 | 3.1 | GO:0005827 | polar microtubule(GO:0005827) |
0.0 | 2.9 | GO:0035578 | azurophil granule lumen(GO:0035578) |
0.6 | 2.6 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
0.5 | 2.4 | GO:0034669 | integrin alpha4-beta7 complex(GO:0034669) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 11.5 | GO:0003823 | antigen binding(GO:0003823) |
0.1 | 8.3 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.3 | 8.2 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.1 | 6.8 | GO:0019843 | rRNA binding(GO:0019843) |
0.0 | 5.1 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.5 | 3.7 | GO:0034191 | apolipoprotein A-I receptor binding(GO:0034191) |
0.9 | 2.6 | GO:0004877 | complement component C4b receptor activity(GO:0001861) complement component C3b receptor activity(GO:0004877) |
0.3 | 2.4 | GO:1990405 | protein antigen binding(GO:1990405) |
0.5 | 2.3 | GO:0047787 | delta4-3-oxosteroid 5beta-reductase activity(GO:0047787) |
0.4 | 2.2 | GO:0052798 | beta-galactoside alpha-2,3-sialyltransferase activity(GO:0052798) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 8.2 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.0 | 2.8 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.0 | 2.6 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.1 | 2.4 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.0 | 1.9 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.0 | 1.9 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.0 | 1.5 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.0 | 1.3 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.0 | 1.1 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.0 | 1.0 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 11.9 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.1 | 7.4 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.0 | 5.2 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.2 | 4.6 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.1 | 2.5 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.2 | 2.3 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.1 | 2.2 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.0 | 1.4 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.1 | 1.3 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.2 | 1.1 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |